Skip to main content
Advertising

Originally published November 30, 2012 at 3:08 PM | Page modified November 30, 2012 at 3:08 PM

  • Share:
             
  • Comments (0)
  • Print

Biotech company closing Bothell site

Drug-discovery activities will be transferred to AMRI facilities in Singapore and its hometown of Albany, N.Y.

By Seattle Times Business staff

Most Popular Comments
Hide / Show comments
No comments have been posted to this article.
Start the conversation >

advertising

New York-based biotechnology researcher AMRI is closing its Bothell site, eliminating 24 jobs.

The company said Friday its drug-discovery activities will be transferred to AMRI facilities in Singapore and its hometown of Albany, N.Y.

AMRI acquired the Bothell operation in 2001. It moved into a 44,000-square-foot facility in 2009 with expectations it would “double the scale of the current operation over the next five years,” according to a company filing at the time.

AMRI, which provides contract research and development services to biotech and pharmaceutical companies, reported losses in four of the past five quarters and recently closed a research site in Hungary that had employed 100.

The Bothell closure will be complete by March 2013. After one-time charges of about $11 million, the closure will save about $2 million a year, AMRI said.

News where, when and how you want it

Email Icon


Advertising